Design, synthesis and antitumour activity evaluation of novel dolutegravir derivatives

Xi-Xi Hou,Long-Fei Mao,Yajie Guo,Chaoxuan Lou,Lan Wang,Rui-Fang Li,Huili Wang,San-Qiang Li,Jian-Xue Yang
DOI: https://doi.org/10.3389/fphar.2023.1238587
IF: 5.6
2023-08-08
Frontiers in Pharmacology
Abstract:Based on the modification of the structure of dolutegravir, we introduced 1,2,3-triazole moieties with different substituted groups and obtained a lot of novel dolutegravir derivatives. The activity of A549 cells treated with the derivatives was examined, and most compounds showed good inhibitory effects. Among them, compounds 4b and 4g were the most effective, and inhibited the growth of A549 cells with IC 50 values of 8.72 ± 0.11 μM and 12.97 ± 0.32 μM, respectively. In addition, compound 4g induced apoptosis and clonal suppression in A549 tumor cells. Compound 4g also activated the LC3 signaling pathway to induce autophagy in tumor cells, and activated the γ-H2AX signaling pathway to induce DNA damage in tumor cells.
pharmacology & pharmacy
What problem does this paper attempt to address?